等待开盘 12-16 09:30:00 美东时间
+0.335
+1.27%
Invitation Homes (INVH) declares $0.30/share quarterly dividend, 3.4% increase from prior dividend of $0.29. Forward yield 4.55% Payable Jan. 16; for shareholders of record Dec. 23; ex-div Dec. 23. Se...
12-15 12:23
Invitation Homes Inc. (NYSE:INVH) ("Invitation Homes," the "Company," or "our"), the nation's premier single-family home leasing and management company, announced today that it has declared a quarterly cash dividend of
12-13 05:16
Stock index futures pointed to a mixed open Friday as AI momentum hit another speed bump. S&P 500 futures (SPX) slipped -0.11%, while Nasdaq futures (US100:IND) declined -0.47%. Dow futures (INDU) buc...
12-12 18:47
Invitation Homes ( ($INVH) ) just unveiled an update. In a presentation for upc...
12-08 20:20
Alexandria Real Estate Equities (ARE) stock was the second-biggest percentage decliner on the S&P 500 this week, after the real estate investment trust (REIT) on Wednesday nearly halved its quarterly ...
12-07 02:57
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
11-26 10:07
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
11-19 11:01
JP Morgan analyst Anthony Paolone maintains Invitation Homes (NYSE:INVH) with a Overweight and lowers the price target from $38 to $37.
11-18 23:52
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58